MENU
+Compare
PILL
ETF ticker: NYSE ARCA
AS OF
Jul 25 closing price
Price
$6.18
Change
-$0.03 (-0.48%)
Net Assets
9.92M

PILL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index... Show more

Category: #Trading
PILL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PILL with price predictions
Jul 25, 2025

PILL's Stochastic Oscillator remains in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PILL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PILL broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on PILL as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PILL just turned positive on July 09, 2025. Looking at past instances where PILL's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

PILL moved above its 50-day moving average on July 01, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PILL advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 180 cases where PILL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF is 39.61B. The market cap for tickers in the group ranges from 96.38M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is PLRX at 96.38M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was 8%. For the same ETF, the average monthly price growth was 16%, and the average quarterly price growth was -22%. LQDA experienced the highest price growth at 35%, while ZVRA experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was -16%. For the same stocks of the ETF, the average monthly volume growth was -6% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 74
Price Growth Rating: 50
SMR Rating: 78
Profit Risk Rating: 79
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
PILL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/